BOD logo

Bod Science Limited Stock Price

ASX:BOD Community·AU$4.3m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

BOD Share Price Performance

AU$0
0.00 (0.00%)
AU$0
0.00 (0.00%)
Price AU$0

BOD Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Medium and slightly overvalued.

6 Risks
0 Rewards

Bod Science Limited Key Details

AU$3.3m

Revenue

AU$1.0m

Cost of Revenue

AU$2.3m

Gross Profit

AU$10.2m

Other Expenses

-AU$8.0m

Earnings

Last Reported Earnings
Jun 30, 2023
Next Reporting Earnings
n/a
-0.045
68.40%
-239.47%
-136.9%
View Full Analysis

About BOD

Founded
2014
Employees
n/a
CEO
Joanne Patterson
WebsiteView website
bodscience.com

Bod Science Limited operates as a cannabis focused drug development and product innovation company in Australia, the United Kingdom, the European Union, and the United States. The company operates through four segments: Medical, Over The Counter (OTC) Cannabidiol/Hemp, OTC Herbals, and Corporate. It engages in the development of cannabidiol and hemp products for consumers; and development and distribution of therapeutics medicinal cannabis products for medical markets. The company provides Flexofytol, an anti-inflammatory derived from a scientifically validated and clinically trialed turmeric extract that helps in improving joint pain and stiffness, joint health, limiting the ageing of cartilage, and reducing inflammation caused by mild arthritis; and Sedistress, a passion flower extract that reduces the symptoms of stress, anxiety, and insomnia, as well as contract manufacturing services. The company was formerly known as Bod Australia Limited and changed its name to Bod Science Limited in December 2022. Bod Science Limited was incorporated in 2014 and is based in Double Bay, Australia.

Recent BOD News & Updates

Recent updates

No updates